Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2025-12-25 @ 8:36 PM
Study NCT ID:
NCT07250269
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2025-10-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
Sponsor:
Gracell Biotechnologies (Shanghai) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-29
Start Date Type:
ACTUAL
Primary Completion Date:
2028-11-24
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-24
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-21
First Submit QC Date:
None
Study First Post Date:
2025-11-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-18
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED